| Record ID | marc_records_scriblio_net/part22.dat:14611202:1402 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part22.dat:14611202:1402?format=raw |
LEADER: 01402cam 2200349 a 4500
001 91025955 //r92
003 DLC
005 19920612091407.9
008 910627s1992 caua b 101 0 eng c
010 $a 91025955 //r92
020 $a0127022953
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC271.C5$bD774 1992
060 $aQZ 267 D79358 1990
082 00 $a616.99/4061$220
245 00 $aDrug resistance as a biochemical target in cancer chemotherapy /$cedited by Takashi Tsuruo, Makoto Ogawa.
260 0 $aSan Diego :$bAcademic Press,$cc1992.
300 $axxv, 342 p. :$bill. ;$c24 cm.
440 0 $aBristol-Myers Squibb cancer symposia ;$v13
500 $aBased on the Bristol-Myers Squibb Drug Resistance in Cancer Symposium, held in Tokyo in 1990.
504 $aIncludes bibliographical references and index.
650 0 $aDrug resistance in cancer cells$xCongresses.
650 0 $aP-glycoprotein$xCongresses.
650 0 $aCancer$xChemotherapy$xComplications$xCongresses.
650 0 $aMultidrug resistance$xCongresses.
650 2 $aAntineoplastic Agents$xpharmacology$xcongresses.
650 2 $aDrug Resistance$xcongresses.
650 2 $aGlycoproteins$xpharmacology$xcongresses.
650 2 $aNeoplasms$xdrug therapy$xcongresses.
700 10 $aTsuruo, Takashi.
700 10 $aOgawa, M.
711 20 $aBristol-Myers Squibb Drug Resistence in Cancer Symposium$d(1990 :$cTokyo, Japan)